UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549 

_________________________________________________________

Amendment No. 1 to FORM 6-K

_________________________________________________________

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13A-16 OR 15D-16 UNDER THE

SECURITIES EXCHANGE ACT OF 1934

Dated May 17, 2018

Commission File Number 001-36421 

_________________________________________________________

AURINIA PHARMACEUTICALS INC.

(Exact name of Registrant as specified in its charter) 

 _________________________________________________________

N/A

(Translation of Registrant's Name)

#1203-4464 Markham Street

Victoria, British Columbia

V8Z 7X8

(250) 708-4272

(Address and telephone number of registrant’s principal executive offices)

 _________________________________________________________

Indicate by check mark whether the registrant files of will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F ☐   Form 40-F   ☒ 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b) (1): ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b) (7): ☐

Indicate by check mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

Yes  ☒            No   ☐

This Form 6-K/A is hereby filed and incorporated by reference in the registrant's Registration Statement on Form F-10 (File No. 333-222413).

 _________________________________________________________

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Date: May 17, 2018	Aurinia Pharmaceuticals Inc.
	By:	/s/ Dennis Bourgeault
	Name: Title:	Dennis Bourgeault Chief Financial Officer

---

EXHIBIT INDEX

This Amendment No. 1 to Form 6-K is being filed solely to refile exhibit 99.3-Information Circular.

Exhibit No.	Document
99.1	Notice of Annual General Meeting of Shareholders
99.2	Notice and Access Notice of Annual General Meeting of Shareholders
99.3	Information Circular
99.4	Form of Proxy

Exhibits 99.1, 99.2, 99.3 and 99.4 included with this report on this Amendment No. 1 to Form 6-K are hereby incorporated by reference as exhibits to the Registration Statement on Form F-10 of Aurinia Pharmaceuticals Inc. (File No. 333-222413), as amended or supplemented.